Literature DB >> 26610159

Pharmacological effects of berberine and its derivatives: a patent update.

Yifeng Jin1, Daulat B Khadka1, Won-Jea Cho1.   

Abstract

INTRODUCTION: A number of plant-derived agents are used in many therapeutic areas. Berberine, an important protoberberine alkaloid, is present in a number of medicinal plants that have been widely used in traditional Chinese medicine for hundreds of years. Modern research has shown that berberine and its derivatives display several pharmacological effects through various mechanisms. AREAS COVERED: This review discusses recent and mostly Chinese patents that report the synthesis of berberine, berberine derivatives and berberine salts, and methods of preparation for formulations (traditional Chinese medicine) containing herbal components rich in berberine, along with their applications. The review covers several therapeutic effects of berberine, its derivatives and pharmaceutical formulations against cancer, obesity, diabetes, inflammation, atherosclerosis, Alzheimer's disease, rheumatoid arthritis and cardiovascular diseases. In addition, the mechanisms underlying the pharmacological effects are discussed. EXPERT OPINION: Modification of the functional groups of berberine has a significant effect on the pharmacological activity. However, studies on altering the atoms and size of the berberine skeleton are rare. Thus, it may be beneficial to initiate a drug development program focused on inserting heterocyclic rings of different sizes into berberine. Furthermore, structural modification to improve the safety, efficacy and selectivity is necessary to promote the use of berberine-based drugs in clinical settings.

Entities:  

Keywords:  Alzheimer’s disease; berberine; cancer; diabetes; inflammation; obesity

Mesh:

Substances:

Year:  2015        PMID: 26610159     DOI: 10.1517/13543776.2016.1118060

Source DB:  PubMed          Journal:  Expert Opin Ther Pat        ISSN: 1354-3776            Impact factor:   6.674


  31 in total

1.  Berberine protects renal tubular cells against hypoxia/reoxygenation injury via the Sirt1/p53 pathway.

Authors:  Yuanbang Lin; Mingwei Sheng; Yijie Ding; Nan Zhang; Yayue Song; Hongyin Du; Ning Lu; Wenli Yu
Journal:  J Nat Med       Date:  2018-04-21       Impact factor: 2.343

2.  Pyridine Derivative of the Natural Alkaloid Berberine as Human Telomeric G4-DNA Binder: A Solution and Solid-State Study.

Authors:  Francesco Papi; Carla Bazzicalupi; Marta Ferraroni; Giulia Ciolli; Paolo Lombardi; Asma Yasmeen Khan; Gopinatha Suresh Kumar; Paola Gratteri
Journal:  ACS Med Chem Lett       Date:  2020-02-07       Impact factor: 4.345

3.  Tetrahydroberberrubine retards heart aging in mice by promoting PHB2-mediated mitophagy.

Authors:  Lei Wang; Xue-Qing Tang; Yang Shi; Hui-Min Li; Zi-Yu Meng; Hui Chen; Xiao-Han Li; Yong-Chao Chen; Heng Liu; Yang Hong; Heng-Hui Xu; Ling Liu; Limin Zhao; Wei-Na Han; Xin Liu; Yong Zhang
Journal:  Acta Pharmacol Sin       Date:  2022-08-10       Impact factor: 7.169

4.  Synergic Effects of Berberine and Curcumin on Improving Cognitive Function in an Alzheimer's Disease Mouse Model.

Authors:  Lin Lin; Cheng Li; Deyi Zhang; Mingxiang Yuan; Chun-Hai Chen; Maoquan Li
Journal:  Neurochem Res       Date:  2020-02-21       Impact factor: 3.996

Review 5.  Isoliensinine: A Natural Compound with "Drug-Like" Potential.

Authors:  Yan Cheng; Hong-Li Li; Zi-Wei Zhou; Hui-Zhi Long; Hong-Yu Luo; Dan-Dan Wen; Lin Cheng; Li-Chen Gao
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 6.  Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease.

Authors:  Wenbin Dai; Longhai Long; Xiaoqiang Wang; Sen Li; Houping Xu
Journal:  Chin Med       Date:  2022-04-28       Impact factor: 4.546

7.  Berberine alleviates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress.

Authors:  Li-Chao Zhang; Yue Wang; Ling-Chang Tong; Sheng Sun; Wei-Ye Liu; Su Zhang; Rong-Mei Wang; Zhi-Bin Wang; Ling Li
Journal:  Exp Ther Med       Date:  2017-04-28       Impact factor: 2.447

8.  Discovery of Isoquinolinoquinazolinones as a Novel Class of Potent PPARγ Antagonists with Anti-adipogenic Effects.

Authors:  Yifeng Jin; Younho Han; Daulat Bikram Khadka; Chao Zhao; Kwang Youl Lee; Won-Jea Cho
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

Review 9.  Role of berberine in Alzheimer's disease.

Authors:  Zhiyou Cai; Chuanling Wang; Wenming Yang
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-03       Impact factor: 2.570

10.  Mitochondria play an important role in the cell proliferation suppressing activity of berberine.

Authors:  Xiao-Jin Yan; Xuan Yu; Xin-Pei Wang; Jing-Fei Jiang; Zhi-Yi Yuan; Xi Lu; Fan Lei; Dong-Ming Xing
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.